Literature DB >> 24866794

CD14 influences host immune responses and alternative activation of macrophages during Schistosoma mansoni infection.

Smanla Tundup1, Leena Srivastava1, Tamas Nagy2, Donald Harn3.   

Abstract

Antigen-presenting cell (APC) plasticity is critical for controlling inflammation in metabolic diseases and infections. The roles that pattern recognition receptors (PRRs) play in regulating APC phenotypes are just now being defined. We evaluated the expression of PRRs on APCs in mice infected with the helminth parasite Schistosoma mansoni and observed an upregulation of CD14 expression on macrophages. Schistosome-infected Cd14(-/-) mice showed significantly increased alternative activation of (M2) macrophages in the livers compared to infected wild-type (wt) mice. In addition, splenocytes from infected Cd14(-/-) mice exhibited increased production of CD4(+)-specific interleukin-4 (IL-4), IL-5, and IL-13 and CD4(+)Foxp3(+)IL-10(+) regulatory T cells compared to cells from infected wt mice. S. mansoni-infected Cd14(-/-) mice also presented with smaller liver egg granulomas associated with increased collagen deposition compared to granulomas in infected wt mice. The highest expression of CD14 was found on liver macrophages in infected mice. To determine if the Cd14(-/-) phenotype was in part due to increased M2 macrophages, we adoptively transferred wt macrophages into Cd14(-/-) mice and normalized the M2 and CD4(+) Th cell balance close to that observed in infected wt mice. Finally, we demonstrated that CD14 regulates STAT6 activation, as Cd14(-/-) mice had increased STAT6 activation in vivo, suggesting that lack of CD14 impacts the IL-4Rα-STAT6 pathway, altering macrophage polarization during parasite infection. Collectively, these data identify a previously unrecognized role for CD14 in regulating macrophage plasticity and CD4(+) T cell biasing during helminth infection.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24866794      PMCID: PMC4136223          DOI: 10.1128/IAI.01780-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  CD14 controls the LPS-induced endocytosis of Toll-like receptor 4.

Authors:  Ivan Zanoni; Renato Ostuni; Lorri R Marek; Simona Barresi; Roman Barbalat; Gregory M Barton; Francesca Granucci; Jonathan C Kagan
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

2.  Association of genetic variants of CD14 with peanut allergy and elevated IgE levels in peanut allergic individuals.

Authors:  Stephen C Dreskin; Andrew Ayars; Ying Jin; Dan Atkins; Harvey L Leo; Benjamin Song
Journal:  Ann Allergy Asthma Immunol       Date:  2010-12-23       Impact factor: 6.347

3.  Schistosoma mansoni worm glycolipids induce an inflammatory phenotype in human dendritic cells by cooperation of TLR4 and DC-SIGN.

Authors:  Caroline M W van Stijn; Sandra Meyer; Marloes van den Broek; Sven C M Bruijns; Yvette van Kooyk; Rudolf Geyer; Irma van Die
Journal:  Mol Immunol       Date:  2010-02-18       Impact factor: 4.407

4.  The effect of CD14 C159T polymorphism on in vitro IgE synthesis and cytokine production by PBMC from children with asthma.

Authors:  C Sackesen; E Birben; O U Soyer; U M Sahiner; T S Yavuz; E Civelek; E Karabulut; M Akdis; C A Akdis; O Kalayci
Journal:  Allergy       Date:  2011-01       Impact factor: 13.146

5.  CD14 is a coreceptor of Toll-like receptors 7 and 9.

Authors:  Christoph L Baumann; Irene M Aspalter; Omar Sharif; Andreas Pichlmair; Stephan Blüml; Florian Grebien; Manuela Bruckner; Pawel Pasierbek; Karin Aumayr; Melanie Planyavsky; Keiryn L Bennett; Jacques Colinge; Sylvia Knapp; Giulio Superti-Furga
Journal:  J Exp Med       Date:  2010-11-15       Impact factor: 14.307

6.  CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation.

Authors:  Ivan Zanoni; Renato Ostuni; Giusy Capuano; Maddalena Collini; Michele Caccia; Antonella Ellena Ronchi; Marcella Rocchetti; Francesca Mingozzi; Maria Foti; Giuseppe Chirico; Barbara Costa; Antonio Zaza; Paola Ricciardi-Castagnoli; Francesca Granucci
Journal:  Nature       Date:  2009-06-14       Impact factor: 49.962

7.  Association of the CD14 gene polymorphism C-159T with allergic rhinitis.

Authors:  Demin Han; Wenyu She; Luo Zhang
Journal:  Am J Rhinol Allergy       Date:  2010 Jan-Feb       Impact factor: 2.467

8.  Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung.

Authors:  Meera G Nair; Yurong Du; Jacqueline G Perrigoue; Colby Zaph; Justin J Taylor; Michael Goldschmidt; Gary P Swain; George D Yancopoulos; David M Valenzuela; Andrew Murphy; Margaret Karow; Sean Stevens; Edward J Pearce; David Artis
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

9.  MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis.

Authors:  Dawn M E Bowdish; Kaori Sakamoto; Mi-Jeong Kim; Mariliis Kroos; Subhankar Mukhopadhyay; Cynthia A Leifer; Karl Tryggvason; Siamon Gordon; David G Russell
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

10.  Retnla (relmalpha/fizz1) suppresses helminth-induced Th2-type immunity.

Authors:  John T Pesce; Thirumalai R Ramalingam; Mark S Wilson; Margaret M Mentink-Kane; Robert W Thompson; Allen W Cheever; Joseph F Urban; Thomas A Wynn
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

View more
  9 in total

1.  An agonist antibody that blocks autoimmunity by inducing anti-inflammatory macrophages.

Authors:  Kyung Ho Han; Rosana Gonzalez-Quintial; Yingjie Peng; Roberto Baccala; Argyrios N Theofilopoulos; Richard A Lerner
Journal:  FASEB J       Date:  2015-10-19       Impact factor: 5.191

2.  TNF Counterbalances the Emergence of M2 Tumor Macrophages.

Authors:  Franz Kratochvill; Geoffrey Neale; Jessica M Haverkamp; Lee-Ann Van de Velde; Amber M Smith; Daisuke Kawauchi; Justina McEvoy; Martine F Roussel; Michael A Dyer; Joseph E Qualls; Peter J Murray
Journal:  Cell Rep       Date:  2015-09-10       Impact factor: 9.423

Review 3.  Role of Macrophages in the Repair Process during the Tissue Migrating and Resident Helminth Infections.

Authors:  Berenice Faz-López; Jorge Morales-Montor; Luis I Terrazas
Journal:  Biomed Res Int       Date:  2016-08-25       Impact factor: 3.411

Review 4.  Metabolic Programming of Macrophages: Implications in the Pathogenesis of Granulomatous Disease.

Authors:  Jayne Louise Wilson; Hannah Katharina Mayr; Thomas Weichhart
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

5.  Monoclonal Antibodies Generated against Glycoconjugates Recognize Chemical Linkers.

Authors:  Jessica Ramadhin; Vanessa Silva-Moraes; Thomas Norberg; Donald Harn
Journal:  Antibodies (Basel)       Date:  2020-09-15

6.  In silico identification of novel biomarkers for key players in transition from normal colon tissue to adenomatous polyps.

Authors:  Zerrin Isik; Asım Leblebici; Ezgi Demir Karaman; Caner Karaca; Hulya Ellidokuz; Altug Koc; Ender Berat Ellidokuz; Yasemin Basbinar
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.752

7.  A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway.

Authors:  Smanla Tundup; Leena Srivastava; Thomas Norberg; Wendy Watford; Donald Harn
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

8.  Variations in CD14 Gene Are Associated With Autoimmune Thyroid Diseases in the Chinese Population.

Authors:  Xi Jia; Bing Wang; Qiuming Yao; Qian Li; Jinan Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-16       Impact factor: 5.555

9.  Ovine CD14- an Immune Response Gene Has a Role Against Gastrointestinal Nematode Haemonchus contortus-A Novel Report.

Authors:  Kavita Rawat; Aruna Pal; Samiddha Banerjee; Abantika Pal; Subhas Chandra Mandal; Subhasis Batabyal
Journal:  Front Immunol       Date:  2021-07-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.